Zydus Lifesciences Ltd. (ZYDUSLIFE)

Overview

Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited, is a prominent provider in the pharmaceutical field, encompassing a broad range of activities from research and development to the production, marketing, and distribution of pharmaceutical products. Established in 1952 and headquartered in Ahmedabad, India, the company has established a significant presence not only in its home country but also in key international markets, including the United States. Operating through two main segments, Pharmaceuticals and Consumer Products, Zydus Lifesciences caters to a diverse portfolio that addresses various therapeutic needs and consumer wellness products. The company's transition to Zydus Lifesciences Limited in February 2022 marks a significant milestone in its journey, emphasizing its evolution and expanded focus in the life sciences spectrum.

Products and Services

• Finished Dosage Human Formulations

  Zydus Lifesciences offers a comprehensive range of finished dosage human formulations that include generics, branded generics, specialty formulations, biosimilars, and vaccines. These products cater to several therapeutic areas including pain management, neurology, metabolic disorders, and liver diseases, providing essential medicines that address the needs of a diverse patient population across the globe.

• Active Pharmaceutical Ingredients (APIs)

  The company produces active pharmaceutical ingredients, serving not only its in-house needs for formulations but also providing these essential components to other pharmaceutical companies globally. This segment underscores Zydus Lifesciences' capabilities in the upstream supply chain of pharmaceutical manufacturing.

• Consumer Wellness Products

  Under its Consumer Products segment, Zydus Lifesciences offers a variety of wellness products to consumers. These include notable brands such as Everyuth, Nutralite, Complan, Glucon D, and Nycil, catering to nutritional, skincare, and health supplement needs. The diverse product range signifies the company's commitment to enhancing consumer health and wellness outside of traditional pharmaceuticals.

• Biological Products Pipeline

  Zydus Lifesciences is also engaged in developing a promising pipeline of biological products aimed at treating conditions across various medical fields such as oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. This pipeline reflects the company's ongoing investment in innovation and its future in addressing unmet medical needs through advanced therapeutic options.

• Additional Business Activities

  Beyond its core pharmaceutical and consumer health products, Zydus Lifesciences engages in several ancillary activities including investment, animal health and veterinary, pharmacy retail, and manpower supply and administration. These diverse engagements demonstrate the company's multifaceted approach to healthcare and its ecosystem, striving to provide comprehensive solutions across the health and wellness space.